Valuation Voyageur Pharmaceuticals Ltd. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 18:20:41 20/07/2026 BST			5-day change	1st Jan Change
0.1000 ^USD	0.00%		0.00%	-23.14%

06-18	Voyageur Pharmaceuticals Evaluates Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility	CI
06-10	Voyageur Pharmaceuticals Ltd Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support At Frances Creek Barite Project	CI

Data adjusted to current consolidation scope

Fiscal Period: November	2020	2021	2022	2023	2024	2025
Market Cap ¹	2.855	9.164	8.025	5.308	9.066	28.55
Change	-	221.01%	-12.43%	-33.85%	70.79%	214.92%
Enterprise Value (EV) ¹	3.197	8.387	8.013	5.343	8.953	28.32
Change	-	162.35%	-4.46%	-33.32%	67.58%	216.31%
P/E	-2.48x	-4.15x	-4.3x	-3.73x	-5.24x	-7.5x
PBR	9.32x	4.81x	5.52x	3.7x	20.1x	22.8x
PEG	-	-0.1x	0.2x	0.1x	-0.3x	-0.1x
Capitalization / Revenue	-	-	-	-	-	2,443,311,938x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-3.25x	-4.25x	-5.02x	-4.38x	-5.92x	-9.79x
EV / EBIT	-2.81x	-4.25x	-4.99x	-4.37x	-5.91x	-9.79x
EV / FCF	-58.1x	-7.96x	-6.73x	-9.15x	14.8x	-17x
FCF Yield	-1.72%	-12.6%	-14.8%	-10.9%	6.74%	-5.89%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0162	-0.0217	-0.0163	-0.0107	-0.0124	-0.0213
Distribution rate	-	-	-	-	-	-
Net sales	-	-	-	-	-	0.0117
EBITDA ¹	-0.9846	-1.972	-1.596	-1.221	-1.513	-2.892
EBIT ¹	-1.138	-1.974	-1.605	-1.223	-1.515	-2.893
Net income ¹	-1.139	-2.051	-1.754	-1.399	-1.707	-3.533
Net Debt ¹	0.3422	-0.7768	-0.012	0.0344	-0.1126	-0.2306
Reference price ²	0.0400	0.0900	0.0700	0.0400	0.0650	0.1600
Nbr of stocks (in thousands)	71,366	101,820	114,638	132,702	139,473	178,438
Announcement Date	30/03/21	17/03/22	30/03/23	26/03/24	31/03/25	27/03/26

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.09x	12.2x	25.51x	0.59%	1,023B
JOHNSON & JOHNSON	26.74x	6.1x	16.7x	2.16%	599B
ABBVIE INC.	33.01x	7.5x	15.37x	2.71%	448B
ROCHE HOLDING AG	17.72x	4.39x	10.82x	3.02%	326B
NOVARTIS AG	21.23x	5.45x	13.2x	2.93%	278B
ASTRAZENECA PLC	20.75x	4.38x	12.12x	2.01%	258B
NOVO NORDISK A/S	14.46x	5.38x	11.08x	3.46%	222B
AMGEN INC.	23.89x	6.31x	11.13x	2.77%	197B
GILEAD SCIENCES, INC.	-47.99x	5.74x	31.73x	2.44%	165B
Average	15.99x	6.38x	16.41x	2.45%	390.56B
Weighted average by Cap.	23.51x	7.66x	17.98x	2.03%